You let us know that you have been diagnosed with ovarian cancer.
You could benefit from the three tests listed below from Myriad Genetics.
- Myriad myRisk® is a hereditary cancer test that may identify the cause of your ovarian cancer, guide treatment decisions, and inform your family if they could be at an elevated risk of developing certain cancers.
- myChoice® CDx is the most comprehensive tumor test to determine your HRD status. Determining your HRD status will provide information on magnitude of benefit for newly FDA-approved advanced therapies.
- BRACAnalysis CDx® is a blood test used to determine if women with advanced or recurrent ovarian cancer can benefit from advanced therapies, such as Lynparza, by determining if you have a BRCA gene mutation.
Fill out the form for additional information and to learn next steps to being tested.